News | May 20, 2008

New Training Guidance Given for Implants of Cardiac Devices in Pediatrics

May 21, 2008 - The Heart Rhythm Society and the Pediatric Congenital Electrophysiology Society (PACES) have released the first training guidelines (PDF, 108K) for physician knowledge and experience for treating this unique patient population. The statement was released today at Heart Rhythm 2008, the Heart Rhythm Society’s 29th Annual Scientific Sessions.

As devices such as pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices become more advanced, these life-saving therapies are being used more frequently in pediatric and congenital heart patients.

The Heart Rhythm Society and PACES developed a task force comprised of adult and pediatric cardiologists as well as adult and pediatric surgeons to prepare the Heart Rhythm Society/PACES Clinical Competency Statement: Training pathways for implantation of cardioverter-defibrillators and cardiac resynchronization therapy devices in pediatric and congenital heart patients. The task force assessed implant volumes and physician background in 49 pediatric programs that implant pacemakers, ICDs and CRT devices, and these findings serve as a framework for the new recommendations.

“Healthcare teams involved in the care of these patients should have proper knowledge and expertise surrounding implantation indications, techniques, programming and follow-up of these devices, as well as the non-technical issues relevant to children,” said the statement’s lead author J. Philip Saul, MD, Professor and Chief of Pediatric Cardiology at the Medical University of South Carolina. “This statement complements prior training guidelines and also establishes new criteria for ICD and CRT implantation in pediatric patients as well as adults with congenital heart disease.”

For more information: www.hrsonline.org

Related Content

Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD)| July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Videos | Implantable Cardioverter Defibrillator (ICD)| June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
The Unify ICD is one of the SJM devices in an FDA warning letter
Feature | Implantable Cardioverter Defibrillator (ICD)| April 14, 2017 | Dave Fornell
April 14, 2017 — The U.S. Food and Drug Administration (FDA) sent a warning letter to Abbott/St.
ICDs, non-ischemic cardiomyopathy, University of Alabama at Birmingham study, Circulation
News | Implantable Cardioverter Defibrillator (ICD)| January 18, 2017
A new study published in Circulation has found there is a 23 percent risk in reduction of all-cause mortality in non-...
ICDs, implantable cardioverter defibrillators, survival rate, elderly patients, JACC study
News | Implantable Cardioverter Defibrillator (ICD)| January 17, 2017
Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac...
Overlay Init